WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company's website for 14 days after the conference.
About TESARO
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.